当然，风险亦不容忽视。Infigratinib是泛FGFR1-4抑制剂，对FGFR1等的抑制可能引起高磷血症等副作用。3期试验中约有4%患者出现轻度、短暂的高磷血症。在儿科长期用药的背景下，其安全性仍需更严格的监测，监管的要求也会更严格。
The letter, titled “We Will Not Be Divided,” calls on the leadership of both companies to “put aside their differences and stand together to continue to refuse the Department of War’s current demands for permission to use our models for domestic mass surveillance and autonomously killing people without human oversight.” These are two lines that Anthropic CEO Dario Amodei has said should not be crossed by his or any other AI company.
，详情可参考旺商聊官方下载
provide suggestions for optimizing individual pages
Natural Neighbour Interpolation